Видео ютуба по тегу Ox2R Agonist

The development of oral orexin receptor 2 agonists for the treatment of narcolepsy type 1
The development of oral orexin receptor 2 agonists for the treatment of narcolepsy type 1
Alkermes and Takeda are Leading a Revolution in Narcolepsy Treatment
Alkermes and Takeda are Leading a Revolution in Narcolepsy Treatment
Sleep Unplugged #178 - Orexin Agonists Are Here: This Is The New Stuff
Sleep Unplugged #178 - Orexin Agonists Are Here: This Is The New Stuff
Targeting orexin-2 receptors to avoid the sedative effects of morphine
Targeting orexin-2 receptors to avoid the sedative effects of morphine
Eisai Status Results of Novel Orexin Receptor Agonist E2086 for Narcoleps | Sep 12, 2025
Eisai Status Results of Novel Orexin Receptor Agonist E2086 for Narcoleps | Sep 12, 2025
Latest developments in narcolepsy treatments
Latest developments in narcolepsy treatments
Orexin receptor 2 signaling and narcolepsy in mice / Curr. Biol., May 5, 2025 (Vol. 35, Issue 9)
Orexin receptor 2 signaling and narcolepsy in mice / Curr. Biol., May 5, 2025 (Vol. 35, Issue 9)
Dr. Glaucomflecken Explains: Oveporexton for Narcolepsy Type 1
Dr. Glaucomflecken Explains: Oveporexton for Narcolepsy Type 1
An update on TAK-861 and orexin agonists in narcolepsy type 1
An update on TAK-861 and orexin agonists in narcolepsy type 1
How Metabolism Affects Blood–Brain-Barrier (BBB) Permeability
How Metabolism Affects Blood–Brain-Barrier (BBB) Permeability
Insights into the orexin receptor type 2 (OX2R) mediated... - Paulina Dragan - Poster - APBJC 2024
Insights into the orexin receptor type 2 (OX2R) mediated... - Paulina Dragan - Poster - APBJC 2024
A New Hope for Narcolepsy: Is the Future Nearly Here?: S3 - Ep3
A New Hope for Narcolepsy: Is the Future Nearly Here?: S3 - Ep3
Phase 2b Trial of Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
Phase 2b Trial of Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
New Narcolepsy Drug Improves Cognition! Oveporexton for Narcolepsy Type 1 Explained
New Narcolepsy Drug Improves Cognition! Oveporexton for Narcolepsy Type 1 Explained
Объяснение роли орексина/гипокретина в развитии сна и нарколепсии (Нейробиология сна) | Оригиналы
Объяснение роли орексина/гипокретина в развитии сна и нарколепсии (Нейробиология сна) | Оригиналы
What Are Hypocretin Agonists? - Sleep Wellness Workshop
What Are Hypocretin Agonists? - Sleep Wellness Workshop
Takeda Pharmaceutical - Data from Landmark Oveporexton (TAK-861) Phase 3 Program in NT1
Takeda Pharmaceutical - Data from Landmark Oveporexton (TAK-861) Phase 3 Program in NT1
Tirzepatide: A Dual Agonist with Metabolic Reprogramming. Reviewed November 6, 2025.
Tirzepatide: A Dual Agonist with Metabolic Reprogramming. Reviewed November 6, 2025.
New Orexin Drug Boosts Cognitive Function in Narcolepsy Type 1 Patients
New Orexin Drug Boosts Cognitive Function in Narcolepsy Type 1 Patients
Increasing alertness using TAK-861 without the side effects associated with traditional therapies
Increasing alertness using TAK-861 without the side effects associated with traditional therapies
Dayvigo (Lamborexant): The New Kid on the Insomnia Block
Dayvigo (Lamborexant): The New Kid on the Insomnia Block
Centessa Pharma's Bold Shift: New CEO & Focus on Sleep Disorder Breakthrough
Centessa Pharma's Bold Shift: New CEO & Focus on Sleep Disorder Breakthrough
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY)
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY)
Seminar - Orexin: Dr Riya Gupta
Seminar - Orexin: Dr Riya Gupta
Orexin as a promising therapeutic target in epilepsy
Orexin as a promising therapeutic target in epilepsy